Publications
Tackling the MDR-TB epidemic in Ukraine: every little helps … and much more needed.
2018
J Public Health (Oxf)
Burman M, Nikolayevskyy V, Kontsevaya I, et al.
DOI:
10.1093/pubmed/fdx014
Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.
2017
Am J Respir Crit Care Med
van Leth F, Günther G, Hoffmann H, et al.
DOI:
10.1164/rccm.201705-0995LE
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.
2017
Eur Respir J
van Ingen J, Wagner D, Gallagher J, et al.
DOI:
10.1183/13993003.01855-2016
Management of child MDR-TB contacts across countries in the WHO European Region: a survey of current practice.
2017
Int J Tuberc Lung Dis
Turkova A, Tebruegge M, Brinkmann F, et al.
DOI:
10.5588/ijtld.16.0949
Treatment outcomes of MDR-TB and HIV co-infection in Europe.
2017
Eur Respir J
Magis-Escurra C, Günther G, Lange C, et al.
DOI:
10.1183/13993003.02363-2016
MDR-TB in Eastern Europe in the era of the TB elimination action framework.
2017
Int J Tuberc Lung Dis
Dudnyk A, Butov D, Crudu V, et al.
DOI:
10.5588/ijtld.16.0732
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
2017
Am J Respir Crit Care Med
Dedicoat MJ, Günther G, Crudu V, et al.
DOI:
10.1164/rccm.201612-2585LE
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study.
2017
Respir Med
Bothamley GH, Lange C, TBNET.
DOI:
10.1016/j.rmed.2017.09.007
The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis.
2017
Breathe (Sheff)
Bothamley G.
DOI:
10.1183/20734735.005517
European shortage of purified protein derivative and its impact on tuberculosis screening practices.
2016
Int J Tuberc Lung Dis
Tebruegge M, Buonsenso D, Brinkmann F, et al.
DOI:
10.5588/ijtld.15.0975
Viral Load and Risk of Tuberculosis in HIV Infection.
2016
J Acquir Immune Defic Syndr
Lange C, van Leth F, Sester M, et al.
DOI:
10.1097/QAI.0000000000000834
More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.
2016
N Engl J Med
Lange C, Günther G, van Leth F, et al.
DOI:
10.1056/NEJMc1613123
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.
2016
Am J Respir Crit Care Med
Lange C, Duarte R, Fréchet-Jachym M, et al.
DOI:
10.1164/rccm.201606-1097LE
The impact of Bacille Calmette-Guérin shortage on immunisation practice and policies in Europe - A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey.
2016
Tuberculosis (Edinb)
Kontturi A, Santiago B, Tebruegge M, et al.
DOI:
10.1016/j.tube.2016.08.005
Treatment Outcomes in Multidrug-Resistant Tuberculosis.
2016
N Engl J Med
Günther G, Lange C, Alexandru S, et al.
DOI:
10.1056/NEJMc1603274